Al/loT-Driven Real-time Cardiac Event Prediction & Treatment

It is anticipated that between 2025 and 2050, a significant 50.2 per cent increase in cardiovascular mortality rates will result in 35.6 million cardiovascular deaths by 2050, of which ischemic heart disease or coronary heart disease will remain the leading cause, accounting for 56.2 per cent of fatalities in 2050.

- Dr Manbeena Chawla

This World Heart Day, celebrated every year on September 29, calls for enhancing diagnostic precision and rapid advancements in cardiac imaging technology for detecting conditions such as ischemic heart disease, arrhythmia, atherosclerosis, atrial fibrillation, cardiac arrest, congenital heart disease etc. As a result, the application of artificial intelligence (AI) and machine learning is rapidly increasing in cardiac healthcare.

The AI-based global cardiology market size estimated at $1.29 billion in 2024, is reportedly projected to grow at a CAGR of 22.81 per cent from 2025 to 2030, where North America leads with the largest revenue share. There are numerous players within the US market that have developed AIbased tools to enhance diagnosis of cardiovascular conditions, supported by the US Food and Drug Administration (FDA). As per available data, there are more than 1000 AI algorithms cleared by the US FDA, where cardiology is at the second number.